Countdown to Bank OZK (OZK) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
The current level reflects an upward revision of 1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Bank OZK metrics that are routinely monitored and predicted by Wall Street analysts.
It is projected by analysts that the 'Efficiency Ratio' will reach 35.6%. Compared to the present estimate, the company reported 32.7% in the same quarter last year.
Analysts predict that the 'Total Average Interest-Earning Assets (FTE)' will reach $36.11 billion. Compared to the current estimate, the company reported $33.58 billion in the same quarter of the previous year.
The average prediction of analysts places 'Total Non-Interest Income' at $32.08 million. Compared to the present estimate, the company reported $28.78 million in the same quarter last year.
Analysts forecast 'Net Interest Income (FTE)' to reach $388.50 million. Compared to the present estimate, the company reported $391.03 million in the same quarter last year.
Analysts' assessment points toward 'Net Interest Income' reaching $371.63 million. The estimate is in contrast to the year-ago figure of $387.99 million.
Analysts expect 'BOLI income- Increase in cash surrender value' to come in at $5.91 million. The estimate is in contrast to the year-ago figure of $5.61 million.
The collective assessment of analysts points to an estimated 'Loan service, maintenance and other fees' of $7.24 million. Compared to the current estimate, the company reported $6.48 million in the same quarter of the previous year.
View all Key Company Metrics for Bank OZK here>>>
Shares of Bank OZK have experienced a change of +15.4% in the past month compared to the +4% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), OZK is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bank OZK (OZK) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
S&P 500 Gains & Losses Today: Amazon Stock Drops; Monolithic Power Surges
Key Takeaways The S&P 500 dropped 1.6% on Friday, Aug. 1, 2025, after the July jobs report revealed an unanticipated level of pressure on the U.S. labor market. Shares of Eastman Chemical plummeted after the maker of specialty chemicals reported year-over-year sales and profit declines. Tech giant Amazon's stock also dropped Friday. Monolithic Power released strong quarterly results, with growth across numerous end markets, and shares of the power management chipmaker U.S. equities indexes tumbled on the final day of the trading week and the first day of the new month after the latest Bureau of Labor Statistics report showed a lower-than-expected pace of hiring in July. The data also showed an uptick in the unemployment rate, along with sharp downward revisions to jobs numbers from May and June. The unexpectedly weak numbers suggest that pressure on the labor market could be more intense than previously believed. That could encourage the Federal Reserve to lower interest rates at its upcoming meetings. The S&P 500 fell 1.6% on Friday, suffering its fourth straight down day as the benchmark index extended its retreat from the record closing high set at the beginning of the week. The Dow ended 1.2% lower, while the Nasdaq dropped 2.2%. Read Investopedia's full daily markets roundup here. Shares of Eastman Chemical (EMN) plunged 19%, experiencing the heaviest decline of any S&P 500 stock. The provider of specialty chemicals reported second-quarter sales and profits that declined year-over and fell short of analysts' expectations. Coinbase Global (COIN), operator of the largest U.S. cryptocurrency exchange, posted second-quarter revenue and adjusted earnings before interest, taxes, depreciation, and amortization that fell short of estimates. Transactions revenue as well as subscriptions and services revenue fell from the previous quarter. Coinbase stock, which fell about 17% on Friday. Although Amazon (AMZN) topped revenue and net income estimates with its second-quarter results, shares of the e-commerce giant slipped 8.3%. Jefferies analysts said growth from the Amazon Web Services cloud computing business was disappointing compared with blowout growth figures from competitor Microsoft (MSFT) and its Azure cloud platform. Other research firms suggested that the pullback in Amazon stock could represent a buying opportunity. The top daily performance in the S&P 500 belonged to shares of Monolithic Power Systems (MPWR), which surged more than 10%. The power management chipmaker reported sales and adjusted profits for the second quarter that surpassed analysts' expectations, boosted by a strong performance in its storage and computing, automotive, and communication markets. Shares of Align Technology (ALGN) advanced 5.8% on Friday, clawing back a portion of the losses posted in the prior session. In quarterly results released Wednesday afternoon, the maker of transparent teeth straighteners and other technological dentistry products reported lower-than-expected sales and profits and announced restructuring measures including workforce cuts. First Solar (FSLR) reported stronger-than-expected sales and profits for the second quarter, and shares of the panel manufacturer jumped 5.3%. The company also increased its full-year sales forecast, and CEO Mark Widmar said shifts in trade policy have strengthened First Solar's position in the industry. Read the original article on Investopedia Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Hamilton Spectator
2 hours ago
- Hamilton Spectator
Wall Street falls the most since May after employers slash hiring and tariffs roll out
The U.S. stock market had its worst day since May on Friday after the government reported a sharp slowdown in hiring and President Donald Trump imposed sweeping tariffs on imports from a number of U.S. trading partners. The S&P 500 fell 1.6%, its biggest decline since May 21 and its fourth straight loss. The index is also posted a 2.4% loss for the week, marking a sharp shift from last week's record-setting streak of gains. The Dow Jones Industrial Average fell 1.2%, while the Nasdaq composite fell 2.2%. Worries on Wall Street about a weakening economy were heavily reinforced by the latest report on job growth in the U.S. Employers added just 73,000 jobs in July. That is sharply lower than economists expected. The Labor Department also reported that revisions shaved a stunning 258,000 jobs off May and June payrolls. Markets also reacted to the latest tariff news . President Donald Trump announced tariff rates on dozens of countries and pushed back the scheduled effective date to Aug. 7, adding more uncertainty to the global trade picture.
Yahoo
3 hours ago
- Yahoo
10 stocks favored to gain up to 30% in a sector that has missed this year's rally
The S&P 500 has returned 9% this year with dividends reinvested. That follows returns for the large-cap U.S. benchmark index of 25% in 2024 and 26.3% in 2023. Are you surprised? Through April 8, the index was down 15% for 2025 in the wake of President Donald Trump's 'liberation day' tariff announcements. This has been a breathtaking rebound rally. But there are always sectors that stand out for underperformance. Here is a ranking of total returns for 2025 through July 30 for the 11 sectors of the S&P 500 SPX, ascending, with the full index at the bottom. All returns in this article include reinvested dividends. Social Security wants to make a change that would cause 3.4 million more people to have to visit its field offices I'm trustee of $65,000 going to my nephew. What are the rules for what I can do with the money? This trader is sounding the alarm over stocks. Why he's pressing the sell button now. Sector or index 2025 return Forward P/E Forward P/E to 5-year average Forward P/E to 10-year average Healthcare -1.6% 16.8 98% 102% Consumer Discretionary -1.0% 29.6 96% 107% Energy 4.3% 15.2 155% 113% Consumer Staples 4.5% 22.5 109% 113% Real Estate 5.2% 18.3 95% 97% Materials 6.6% 20.7 113% 119% Financials 9.8% 16.8 109% 114% Communication Services 11.5% 19.8 103% 104% Information Technology 14.0% 30.1 118% 143% Utilities 14.1% 18.4 103% 105% Industrials 16.1% 25.3 117% 129% S&P 500 9.0% 22.6 111% 120% Source: FactSet You might need to scroll the table to see all of the data. The table includes forward price-to-earnings ratios for the sectors and the full index and their current levels relative to five- and 10-year averages. These are ratios of prices divided by rolling 12-month consensus earnings-per-share estimates among analysts polled by FactSet, weighted by market capitalization. The healthcare sector is tied with the financial sector for the lowest P/E, and the healthcare sector is one of only three sectors trading below five-year average P/E valuations. It also trades second-lowest to its 10-year P/E, with the real-estate sector cheapest on this basis. Two sectors have had negative total returns so far this year. But a deeper look shows the healthcare sector standing out as this year's weakest performer. There are 60 stocks in the healthcare sector and 32 of them were down for 2025 through Wednesday. Among the 51 stocks in the consumer-discretionary sector, only 19 of the stocks were down for 2025 through Wednesday. The consumer discretionary sector is top-heavy. At the end of 2024, Inc. AMZN made up 37% of the sector's market cap, while Tesla made up 21%. Amazon's stock was up 5% for 2025 through Wednesday, but Tesla Inc. TSLA was down 21% — it placed a drag on the entire sector, putting its return in the red so far in 2025. Here are two examples of exchange-traded funds that make it easy to invest in the entire S&P 500 healthcare sector. The Health Care Select Sector SPDR ETF XLV tracks the sector by holding all of its stocks, weighted by market cap. And for a broad approach that doesn't play favorites, there is the Invesco S&P 500 Equal Weight Health Care ETF RSPH. To set the stage for a healthcare sector screen, let's look at the sectors of the S&P 500 again, this time sorting by projected compound annual growth rates (CAGR) for revenue from 2025 through 2027, based on consensus estimates among analysts polled by FactSet. Sector or index Estimated revenue CAGR from 2025 through 2027 Estimated EPS CAGR from 2025 through 2027 Information Technology 7.8% 16.1% Industrials 6.7% 15.1% Communication Services 6.7% 11.1% Real Estate 6.6% 6.9% Consumer Discretionary 5.8% 14.9% Healthcare 5.8% 11.5% Financials 5.4% 12.1% Utilities 5.1% 8.3% Materials 4.2% 14.8% Energy 3.7% 17.7% Consumer Staples 0.8% 7.3% S&P 500 5.4% 13.2% Source: FactSet The information-technology sector is expected to increase revenue and EPS most rapidly over the next two years, which helps explain why its forward P/E ratio (in the first table above) is the highest among the 11 sectors in the S&P 500. The healthcare sector is in the middle of the pack, with a projected revenue CAGR higher than that of the full S&P 500 (bottom row of the table) but a projected EPS CAGR below that of the index. To screen the 60 companies in the S&P 500 healthcare sector, we first limited the list to companies with majority 'buy' or equivalent ratings among analysts polled by FactSet. Then we sorted the remaining list by projected revenue CAGR. Here are the 10 that top the list, along with analysts' consensus price targets: Company Ticker Est. revenue CAGR from 2025 through 2027 Est. EPS CAGR from 2025 through 2027 July 30 price Cons. price target Implied 12-month upside potential Eli Lilly & Co. LLY 18.5% 30.6% $760.08 $989.00 30% Insulet Corp. PODD 17.3% 24.6% $298.27 $343.17 15% DexCom Inc. DXCM 14.9% 23.4% $89.06 $103.36 16% Intuitive Surgical Inc. ISRG 14.8% 14.8% $500.51 $594.12 19% Boston Scientific Corp. BSX 10.5% 13.6% $106.76 $125.43 17% Vertex Pharmaceuticals Inc. VRTX 10.3% 14.8% $469.16 $510.16 9% Edwards Lifesciences Corp. EW 10.1% 12.2% $81.16 $88.21 9% Bio-Techne Corp. TECH 8.5% 13.8% $57.71 $66.71 16% Cardinal Health Inc. CAH 8.5% 12.9% $157.90 $182.57 16% Stryker Corp. SYK 8.5% 11.5% $400.41 $433.31 8% Source: FactSet Any stock screen is based on a limited set of data. Before buying any individual stock, you should do your own research and form your own opinion about how likely the company is to remain competitive over the next decade. One way to begin that process is by clicking the tickers for more information. Read: Tomi Kilgore's detailed guide to the information available on the MarketWatch quote page Other recent deep dives: 'I have never been asked for money before': My friend wants to borrow $1,600 to pay her rent. Do I say yes? Amazon's stock is falling, as this trend from earnings has investors worried Apple's earnings were good, but the initial stock move implies Wall Street is wary Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
